Amplia Therapeutics LtdAmplia Therapeutics Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The ESG rating includes 17 UN Sustainable Development Goals including: 'Quality Education', 'Sustainable Cities & Communities' and 'Peace, Justice & Strong Institutions'. This report of Amplia Therapeutics Ltd employs data from across the internet as well as from public filings by Amplia Therapeutics Ltd. This Sustainability assessment for Amplia Therapeutics Ltd represents its reporting of the United Nations SDGs.

Amplia Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 5.3, social score of 8.0 and governance score of 6.7.

SDG Transparency Score for Amplia Therapeutics Ltd 
Low
0 - 3

6.7

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Amplia Therapeutics Ltd 
5.3

Environmental

8.0

Social

6.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
432Twist Bioscience Corp
6.8
High
432Rhythm Pharmaceuticals Inc
6.8
High
446Amplia Therapeutics Ltd
6.7
High
446Actinium Pharmaceuticals Inc
6.7
High
446AnGes Inc
6.7
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Amplia Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd offer flexible work?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose water use targets?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Amplia Therapeutics Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Amplia Therapeutics Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Amplia Therapeutics Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Amplia Therapeutics Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Amplia Therapeutics Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Amplia Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.

Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase (FAK) inhibitors for oncology and chronic fibrosis in Australia. The company's product pipeline includes AMP945, an inhibitor of FAK, for pancreatic cancer and idiopathic pulmonary fibrosis, as well as other cancers and fibrotic diseases indications, that has completed Phase I clinical trial; and AMP886 for cancer and fibrotic disease indication. It has a collaboration agreement with the Garvan Institute of Media Research in Sydney. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

Sorry!

Failed to process!